Advertisement
Canada markets open in 6 hours 6 minutes

  • S&P/TSX

    21,885.38
    +11.66 (+0.05%)
     

  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     

  • DOW

    38,085.80
    -375.12 (-0.98%)
     

  • CAD/USD

    0.7326
    +0.0003 (+0.04%)
     

  • CRUDE OIL

    84.18
    +0.61 (+0.73%)
     

  • Bitcoin CAD

    87,881.34
    +140.08 (+0.16%)
     

  • CMC Crypto 200

    1,388.27
    -8.26 (-0.59%)
     

  • GOLD FUTURES

    2,350.60
    +8.10 (+0.35%)
     

  • RUSSELL 2000

    1,981.12
    -14.31 (-0.72%)
     

  • 10-Yr Bond

    4.7060
    +0.0540 (+1.16%)
     

  • NASDAQ futures

    17,753.25
    +185.75 (+1.06%)
     

  • VOLATILITY

    15.37
    0.00 (0.00%)
     

  • FTSE

    8,128.46
    +49.60 (+0.61%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • CAD/EUR

    0.6827
    +0.0006 (+0.09%)
     

Lawsuit for Investors Who Purchased Shares of Depomed Inc. (NASDAQ: DEPO) Announced by Shareholders Foundation

ACCESSWIRE

SAN DIEGO, CA / ACCESSWIRE / November 28, 2017 / The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors who purchased NASDAQ: DEPO shares against Depomed Inc.

Investors who purchased shares of Depomed Inc. (DEPO) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

On August 18, 2017, a securities class action lawsuit was filed against Depomed Inc. over alleged securities laws violations. The plaintiff claims that the defendants made false and/or misleading statements and/or failed to disclose that Depomed engaged in questionable practices in connection with the sales and marketing of the Company's opioid products, that the foregoing conduct, when it became known, would likely subject the Company to heightened legal and regulatory scrutiny, and that as a result, Depomed's public statements were materially false and misleading at all relevant times.

Those who purchased Depomed Inc. (DEPO) shares should contact the Shareholders Foundation, Inc.

ADVERTISEMENT

The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

CONTACT:

Shareholders Foundation, Inc.
Michael Daniels
+1 (858) 779-1554
mail@shareholdersfoundation.com
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108

SOURCE: Shareholders Foundation, Inc.